GenCefe Biotech to Exhibit at BioJapan 2025
GenCefe Biotech is pleased to announce its participation in BioJapan 2025, taking place from October 8 to 10 at PACIFICO Yokohama, Japan. As one of the most influential biotechnology events in Asia, BioJapan provides a premier platform for international collaboration, business development, and innovation exchange.
At Booth D-47, GenCefe Biotech will present its advanced technology platforms and service portfolio, covering gene synthesis, DNA/RNA oligo synthesis, peptide synthesis, and cell-free protein expression. With a strong focus on quality, innovation, and customer needs, GenCefe continues to provide reliable solutions that accelerate research and biopharmaceutical development worldwide.
Our professional BD team will be present throughout the exhibition to meet with partners and customers. We warmly welcome attendees to visit our booth and engage in discussions on how GenCefe can support your scientific and industrial projects.
For meeting arrangements or further inquiries, please contact us at [email protected].
About BioJapan
BioJapan is Asia's premier bio-industry partnering event, comprising an Exhibition, Seminars, and Partnering sessions.
As the world’s longest-running biotech exhibition, BioJapan, along with its two co-located events —Regenerative Medicine Japan, which accelerates R&D and commercialization in regenerative medicine, and healthTECH Japan, focusing on health management, diagnostics, and therapeutics through the integration of digital technology and life sciences— continues to drive innovation and collaboration in the industry.
About GenCefe Biotech
GenCefe Biotech was established in Wuxi, China in 2020, and started its US branch in California in 2021. The company focuses on advanced technology development, large-scale production, and applications of DNA, RNA, gene, and protein synthesis. We are committed to breaking through industry bottlenecks with advanced automation synthesis and AI platforms, promoting the development of synthetic biology, drug discovery, and molecular diagnostics. GenCefe has earned ISO 9001 and ISO 13485 certifications and currently serves customers in more than 20 countries worldwide.